GlassScriptPhysician profile
Jesse Hackell
NPI 1730278185
$17,006.21
in general payments reported to CMS, 2019-2025
13 companies · $141 in 2025
The $141 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,883 · 2020: $122 · 2021: $307 · 2022: $2,677 · 2024: $8,876 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,024 · Food and Beverage: $567 · Travel and Lodging: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,024.00 |
| Food and Beverage | $566.66 |
| Travel and Lodging | $426.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $7,226.98 | 2021-2024 | |
| Glaxosmithkline, LLC. | $4,889.62 | 2019-2022 | |
| Alk-Abello, INC | $2,579.53 | 2022 | |
| Sanofi Pasteur INC. | $1,643.57 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $218.89 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $128.03 | 2019-2021 | |
| Pfizer INC. | $83.05 | 2019-2022 | |
| Sobi, INC | $62.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.14 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $47.05 | 2019 | |
| Kaleo, INC. | $31.05 | 2021-2022 | |
| Shire North American Group INC | $20.65 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Hackell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.